10x Genomics (TXG) Cash from Operations Growth (1y) (2019 - 2026)

10x Genomics (TXG) Cash from Operations Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Veeva Systems 31.58 Bn 24.27 Bn 662.02 Mn 28.50%
2 BrightSpring Health Services 14.80 Bn 13.90 Bn 482.22 Mn 21.01%
3 Healthequity 8.18 Bn 7.91 Bn 256.31 Mn 50.65%
4 10x Genomics 5.97 Bn 5.43 Bn 106.18 Mn -23.96%
5 Hinge Health 5.90 Bn 5.58 Bn 154.23 Mn 774.78%
6 MiniMed 4.49 Bn 4.19 Bn 480.00 Mn -304.82%
7 Waystar Holding 4.42 Bn 4.36 Bn 216.84 Mn 32.16%
8 Doximity 3.90 Bn 3.15 Bn 125.97 Mn 11.20%
9 Privia Health 3.19 Bn 2.77 Bn - -105.58%
10 Omnicell 1.88 Bn 1.64 Bn 140.36 Mn 110.23%

Historic Data

Download Data
DateValue
Mar 31, 2026 -23.96%
Dec 31, 2025 704.28%
Sep 30, 2025 99.69%
Jun 30, 2025 136.23%
Mar 31, 2025 318.45%
Dec 31, 2024 -126.20%
Sep 30, 2024 185.52%
Jun 30, 2024 165.04%
Mar 31, 2024 -281.21%
Dec 31, 2023 87.70%
Sep 30, 2023 -164.58%
Jun 30, 2023 32.05%
Mar 31, 2023 80.17%
Dec 31, 2022 136.40%
Sep 30, 2022 63.52%
Jun 30, 2022 -643.69%
Mar 31, 2022 -409.60%
Dec 31, 2021 104.46%
Sep 30, 2021 52.87%
Jun 30, 2021 110.57%